Skip to main content
Top
Published in: Indian Journal of Gastroenterology 4/2023

02-06-2023 | Gastroesophageal Reflux Disease | Original Article

Twenty-four-hour pH metry alone is inferior to additional impedance monitoring in the diagnosis of gastroesophageal reflux disease, particularly in presence of reduced gastric acid secretion

Authors: Uday C. Ghoshal, Sugata Narayan Biswas, Anshuman Elhence, Bushra Fatima, Anand Prakash Agrahari, Asha Misra

Published in: Indian Journal of Gastroenterology | Issue 4/2023

Login to get access

Abstract

Background

Current gold standard for the diagnosis of gastroesophageal reflux disease (GERD) is 24-hour pH metry though it fails to detect non-acidic reflux. The sensitivity of 24-hour pH metry alone (both catheter-based and Bravo capsule) is questionable, especially if gastric acid secretion is low due to reduced parietal cell mass, Helicobacter pylori–induced gastric atrophy and antisecretory therapy. Accordingly, we analyzed the diagnostic ability of 24-hour pH metry as compared to impedance monitoring in relation to the gastric pH without antisecretory therapy.

Methods

A retrospective analysis of prospectively collected data from 150 patients with suspected GERD undergoing a 24-hour pH impedance study was done.

Results

Among 150 patients with symptoms suggestive of GERD, 106 (70.6%) had confirmed GERD diagnosed either by 24-hour pH metry alone (10 [9.4%]), impedance monitoring alone (49 [46.2%]) or both (47 [44.3%]). Abnormal reflux of acidic and non-acidic gastric contents was detected by 24-hour pH metry and 24-hour impedance monitoring in 57/106 (53.7%) and 96/106 (90.5%) of patients, respectively (p < .00001). Patients with GERD diagnosed by 24-hour impedance monitoring had a higher mean gastric pH (2.9 [median 1.3, IQR 5.3]) than those diagnosed by 24-hour pH metry (2.1 [median 1.4, IQR 2.6]) or both (1.6 [median 1.2, IQR 2.1]) (p = 0.001).

Conclusion

Twenty-four-hour impedance monitoring detects GERD more often than 24-hour pH metry. Patients with higher mean gastric pH leading to non-acidic reflux were more often diagnosed by 24-hour impedance monitoring than 24-hour pH metry. Thus, 24-hour pH metry alone is inferior to additional impedance monitoring in the diagnosis of GERD, particularly in presence of reduced gastric acid secretion.
Literature
1.
go back to reference Wiener GJ, Morgan TM, Copper JB, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci. 1988;33:1127–33.CrossRefPubMed Wiener GJ, Morgan TM, Copper JB,  et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci. 1988;33:1127–33.CrossRefPubMed
2.
go back to reference Fass R, Hell R, Sampliner RE, et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci. 1999;44:2263–9.CrossRefPubMed Fass R, Hell R, Sampliner RE,  et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci. 1999;44:2263–9.CrossRefPubMed
3.
go back to reference Bollschweiler E, Feussner H, Holscher AH, Siewert JR. pH monitoring: the gold standard in detection of gastrointestinal reflux disease? Dysphagia. 1993;8:118–21.CrossRefPubMed Bollschweiler E, Feussner H, Holscher AH, Siewert JR. pH monitoring: the gold standard in detection of gastrointestinal reflux disease? Dysphagia. 1993;8:118–21.CrossRefPubMed
4.
go back to reference Monkemuller K, Neumann H, Fry LC, Kolfenbach S, Malfertheiner P. Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD). Z Gastroenterol. 2009;47:351–6.CrossRefPubMed Monkemuller K, Neumann H, Fry LC, Kolfenbach S, Malfertheiner P. Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD). Z Gastroenterol. 2009;47:351–6.CrossRefPubMed
5.
go back to reference Forootan M, Zojaji H, Ehsani MJ, Darvishi M. Advances in the diagnosis of GERD using the esophageal pH monitoring, gastro-esophageal impedance-pH monitoring, and pitfalls. Open Access Maced J Med Sci. 2018;6:1934–40.CrossRefPubMedPubMedCentral Forootan M, Zojaji H, Ehsani MJ, Darvishi M. Advances in the diagnosis of GERD using the esophageal pH monitoring, gastro-esophageal impedance-pH monitoring, and pitfalls. Open Access Maced J Med Sci. 2018;6:1934–40.CrossRefPubMedPubMedCentral
6.
go back to reference Sararu ER, Enciu V, Peagu R, Fierbinteanu-Braticevici C. Advances in the diagnosis of GERD. Rom J Intern Med. 2021;59:3–9.PubMed Sararu ER, Enciu V, Peagu R, Fierbinteanu-Braticevici C. Advances in the diagnosis of GERD. Rom J Intern Med. 2021;59:3–9.PubMed
7.
go back to reference Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351–62. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351–62.
8.
go back to reference Dhiman RK, Saraswat VA, Naik SR. Ambulatory esophageal pH monitoring: technique, interpretations, and clinical indications. Dig Dis Sci. 2002;47:241–50. Dhiman RK, Saraswat VA, Naik SR. Ambulatory esophageal pH monitoring: technique, interpretations, and clinical indications. Dig Dis Sci. 2002;47:241–50.
9.
go back to reference Saraswat VA, Dhiman RK, Mishra A, Naik SR. Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease. Dig Dis Sci. 1994;39:199–205.CrossRefPubMed Saraswat VA, Dhiman RK, Mishra A, Naik SR. Correlation of 24-hr esophageal pH patterns with clinical features and endoscopy in gastroesophageal reflux disease. Dig Dis Sci. 1994;39:199–205.CrossRefPubMed
10.
go back to reference Hila A, Agrawal A, Castell DO. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol. 2007;5:172–7.CrossRefPubMed Hila A, Agrawal A, Castell DO. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux. Clin Gastroenterol Hepatol. 2007;5:172–7.CrossRefPubMed
11.
go back to reference Skopnik H, Silny J, Heiber O, Schulz J, Rau G, Heimann G. Gastroesophageal reflux in infants: evaluation of a new intraluminal impedance technique. J Pediatr Gastroenterol Nutr. 1996;23:591–8. Skopnik H, Silny J, Heiber O, Schulz J, Rau G, Heimann G. Gastroesophageal reflux in infants: evaluation of a new intraluminal impedance technique. J Pediatr Gastroenterol Nutr. 1996;23:591–8.
12.
go back to reference Nguyen HN, Domingues GR, Lammert F. Technological insights: combined impedance manometry for esophageal motility testing-current results and further implications. World J Gastroenterol. 2006;12:6266–73.CrossRefPubMedPubMedCentral Nguyen HN, Domingues GR, Lammert F. Technological insights: combined impedance manometry for esophageal motility testing-current results and further implications. World J Gastroenterol. 2006;12:6266–73.CrossRefPubMedPubMedCentral
13.
go back to reference Shay SS, Bomeli S, Richter J. Multichannel intraluminal impedance accurately detects fasting, recumbent reflux events and their clearing. Am J Physiol Gastrointest Liver Physiol. 2002;283:G376–83.CrossRefPubMed Shay SS, Bomeli S, Richter J. Multichannel intraluminal impedance accurately detects fasting, recumbent reflux events and their clearing. Am J Physiol Gastrointest Liver Physiol. 2002;283:G376–83.CrossRefPubMed
14.
go back to reference Sifrim D, Holloway R, Silny J, et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology. 2001;120:1588–98.CrossRefPubMed Sifrim D, Holloway R, Silny J,  et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology. 2001;120:1588–98.CrossRefPubMed
15.
go back to reference Roman S, Gyawali CP, Savarino E, et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017;29:1–15. Roman S, Gyawali CP, Savarino E,  et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017;29:1–15.
16.
go back to reference Bredenoord AJ. Impedance-pH monitoring: new standard for measuring gastro-oesophageal reflux. Neurogastroenterol Motil. 2008;20:434–9. Bredenoord AJ. Impedance-pH monitoring: new standard for measuring gastro-oesophageal reflux. Neurogastroenterol Motil. 2008;20:434–9.
17.
go back to reference Tutuian R, Castell DO. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance. Aliment Pharmacol Ther. 2006;24 Suppl 2:27–37. Tutuian R, Castell DO. Review article: complete gastro-oesophageal reflux monitoring - combined pH and impedance. Aliment Pharmacol Ther. 2006;24 Suppl 2:27–37.
18.
go back to reference Shay S, Tutuian R, Sifrim D, et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99:1037–43. Shay S, Tutuian R, Sifrim D,  et al. Twenty-four hour ambulatory simultaneous impedance and pH monitoring: a multicenter report of normal values from 60 healthy volunteers. Am J Gastroenterol. 2004;99:1037–43.
19.
go back to reference Zentilin P, Iiritano E, Dulbecco P, et al. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis. 2006;38:226–32.CrossRefPubMed Zentilin P, Iiritano E, Dulbecco P,  et al. Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis. 2006;38:226–32.CrossRefPubMed
20.
go back to reference Zerbib F, des Varannes SB, Roman S, et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther. 2005;22:1011–21.CrossRefPubMed Zerbib F, des Varannes SB, Roman S,  et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther. 2005;22:1011–21.CrossRefPubMed
21.
go back to reference Dhiman RK, Saraswat VA, Mishra A, Naik SR. Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease. Dig Dis Sci. 1996;41:764–72.CrossRefPubMed Dhiman RK, Saraswat VA, Mishra A, Naik SR. Inclusion of supine period in short-duration pH monitoring is essential in diagnosis of gastroesophageal reflux disease. Dig Dis Sci. 1996;41:764–72.CrossRefPubMed
22.
go back to reference Hakanson BS, Berggren P, Granqvist S, Ljungqvist O, Thorell A. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring. Scand J Gastroenterol. 2009;44:276–83.CrossRefPubMed Hakanson BS, Berggren P, Granqvist S, Ljungqvist O, Thorell A. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring. Scand J Gastroenterol. 2009;44:276–83.CrossRefPubMed
23.
go back to reference Gillies RS, Stratford JM, Booth MI, Dehn TC. Oesophageal pH monitoring using the Bravo catheter-free radio capsule. Eur J Gastroenterol Hepatol. 2007;19:57–63.CrossRefPubMed Gillies RS, Stratford JM, Booth MI, Dehn TC. Oesophageal pH monitoring using the Bravo catheter-free radio capsule. Eur J Gastroenterol Hepatol. 2007;19:57–63.CrossRefPubMed
24.
go back to reference des Varannes SB, Mion F, Ducrotte P, et al. 2005 Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut. 2005;54:1682–6.CrossRefPubMedPubMedCentral des Varannes SB, Mion F, Ducrotte P,  et al. 2005 Simultaneous recordings of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut. 2005;54:1682–6.CrossRefPubMedPubMedCentral
25.
go back to reference Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 2003;98:740–9.CrossRefPubMed Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 2003;98:740–9.CrossRefPubMed
26.
go back to reference Naik SR, Bajaj SC, Goyal RK, Gupta DN, Chuttani HK. Parietal cell mass in healthy human stomach. Gastroenterology. 1971;61:682–5.CrossRefPubMed Naik SR, Bajaj SC, Goyal RK, Gupta DN, Chuttani HK. Parietal cell mass in healthy human stomach. Gastroenterology. 1971;61:682–5.CrossRefPubMed
27.
go back to reference Smolka AJ, Schubert ML. Helicobacter pylori-induced changes in gastric acid secretion and upper gastrointestinal disease. Curr Top Microbiol Immunol. 2017;400:227–52.PubMed Smolka AJ, Schubert ML. Helicobacter pylori-induced changes in gastric acid secretion and upper gastrointestinal disease. Curr Top Microbiol Immunol. 2017;400:227–52.PubMed
28.
go back to reference Chourasia D, Misra A, Tripathi S, Krishnani N, Ghoshal UC. Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry. Indian J Gastroenterol. 2011;30:12–21. Chourasia D, Misra A, Tripathi S, Krishnani N, Ghoshal UC. Patients with Helicobacter pylori infection have less severe gastroesophageal reflux disease: a study using endoscopy, 24-hour gastric and esophageal pH metry. Indian J Gastroenterol. 2011;30:12–21.
29.
go back to reference Galmiche JP. Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application? Gut. 2006;55:1379–81. Galmiche JP. Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application? Gut. 2006;55:1379–81.
30.
go back to reference Tutuian R. Update in the diagnosis of gastroesophageal reflux disease. J Gastrointestin Liver Dis. 2006;15:243–7.PubMed Tutuian R. Update in the diagnosis of gastroesophageal reflux disease. J Gastrointestin Liver Dis. 2006;15:243–7.PubMed
31.
go back to reference Bajbouj M, Becker V, Neuber M, Schmid RM, Meining A. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion. 2007;76:223–8.CrossRefPubMed Bajbouj M, Becker V, Neuber M, Schmid RM, Meining A. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion. 2007;76:223–8.CrossRefPubMed
32.
go back to reference Blondeau K, Tack J. Pro: impedance testing is useful in the management of GERD. Am J Gastroenterol. 2009;104:2664–6. Blondeau K, Tack J. Pro: impedance testing is useful in the management of GERD. Am J Gastroenterol. 2009;104:2664–6.
33.
go back to reference Ghoshal UC, Singh R, Misra A. Esophageal function tests in clinical practice: a review. Trop Gastroenterol. 2010;31:145–54. Ghoshal UC, Singh R, Misra A. Esophageal function tests in clinical practice: a review. Trop Gastroenterol. 2010;31:145–54.
34.
go back to reference Bhatia SJ, Makharia GK, Abraham P, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38:411–40. Bhatia SJ, Makharia GK, Abraham P,  et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38:411–40.
35.
go back to reference Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334:1018–22.CrossRefPubMed Kuipers EJ, Lundell L, Klinkenberg-Knol EC,  et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med. 1996;334:1018–22.CrossRefPubMed
36.
go back to reference Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Am J Gastroenterol. 2009;104:2704–13. Chourasia D, Achyut BR, Tripathi S, Mittal B, Mittal RD, Ghoshal UC. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease. Am J Gastroenterol. 2009;104:2704–13.
37.
go back to reference Ghoshal UC, Chourasia D. Gastroesophageal reflux disease and Helicobacter pylori: what may be the relationship? J Neurogastroenterol Motil. 2010;16:243–50. Ghoshal UC, Chourasia D. Gastroesophageal reflux disease and Helicobacter pylori: what may be the relationship? J Neurogastroenterol Motil. 2010;16:243–50.
38.
go back to reference Achyut BR, Moorchung N, Mittal B. Genetic association of interleukin-1 haplotypes with gastritis and precancerous lesions in North Indians. Clin Exp Med. 2008;8:23–9.CrossRefPubMed Achyut BR, Moorchung N, Mittal B. Genetic association of interleukin-1 haplotypes with gastritis and precancerous lesions in North Indians. Clin Exp Med. 2008;8:23–9.CrossRefPubMed
39.
go back to reference Chourasia D, Ghoshal UC. Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play? Trop Gastroenterol. 2008;29:13–9. Chourasia D, Ghoshal UC. Pathogenesis of gastro-oesophageal reflux disease: what role do Helicobacter pylori and host genetic factors play? Trop Gastroenterol. 2008;29:13–9.
40.
go back to reference Singh K, Ghoshal UC. Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol. 2006;12:1346–51. Singh K, Ghoshal UC. Causal role of Helicobacter pylori infection in gastric cancer: an Asian enigma. World J Gastroenterol. 2006;12:1346–51.
41.
go back to reference Rai S, Kulkarni A, Ghoshal UC. Prevalence and risk factors for gastroesophageal reflux disease in the Indian population: a meta-analysis and meta-regression study. Indian J Gastroenterol. 2021;40:209–19. Rai S, Kulkarni A, Ghoshal UC. Prevalence and risk factors for gastroesophageal reflux disease in the Indian population: a meta-analysis and meta-regression study. Indian J Gastroenterol. 2021;40:209–19.
Metadata
Title
Twenty-four-hour pH metry alone is inferior to additional impedance monitoring in the diagnosis of gastroesophageal reflux disease, particularly in presence of reduced gastric acid secretion
Authors
Uday C. Ghoshal
Sugata Narayan Biswas
Anshuman Elhence
Bushra Fatima
Anand Prakash Agrahari
Asha Misra
Publication date
02-06-2023
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 4/2023
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-023-01359-3

Other articles of this Issue 4/2023

Indian Journal of Gastroenterology 4/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.